Dexmedetomidine for analgesia and sedation for procedural pain or discomfort in newborn infants
Neonatal Medicine
Dexmedetomidine for analgesia and sedation for procedural pain or discomfort in newborn infants
Neonatal Medicine

Dexmedetomidine for analgesia and sedation for procedural pain or discomfort in newborn infants

Cochrane Database Syst Rev. 2025 Jan 28;1:CD014212. doi: 10.1002/14651858.CD014212.

ABSTRACT

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of dexmedetomidine compared with opioids, non-opioids and placebo in providing sedation and analgesia for procedural pain in newborn infants.

PMID:39873291 | DOI:10.1002/14651858.CD014212